What are the recommendations for COVID-19 nebulizer use? Should they be discontinued in the inpatient or LTC environment to reduce the risk of spread even if there are no positive or PUI cases?

Comment by InpharmD Researcher

There are no clear guidelines for nebulization in patients with suspected or unknown COVID-19 status. Recommendations vary, but if a SARS-COV-2 positive patient requires nebulization then HCPs should be fully garbed with a respiratory mask (e.g. N95).

Background

The Centers for Disease Control and Prevention (CDC) recommends taking precautions when performing aerosol-generating procedures (AGPs). The healthcare provider in the room should wear an N95 or higher-level respirator, and the number of healthcare providers present during the procedure should be limited only to those essential for patient care and procedure support. Aerosol generating procedures should ideally take place in an airborne infection isolation room (AIIR), and the procedure room should be cleaned and disinfected promptly. Nebulizer therapy use corresponds to high-risk exposure for healthcare professionals. [1]

If nebulization is being used in clinical settings for a patient with COVID-19, the American College of Allergy, Asthma, and Immunology (AAAI) recommends healthcare workers use full PPE (gown, gloves, eye protection, and a respiratory mask [e.g. N95]) when having close contact with the patient while they are getting a nebulization. There are no clear guidelines for suspected or unknown COVID-19 patients. In the absence of official recommendations, one expert suggests using patient history and professional judgment (i.e. if the patient had a recent travel history, it may be prudent to act as if there is a SARS-COV-2 infection). [2], [3]

The AAAI recommends continuing routine asthma to control symptoms. Patients diagnosed with COVID-19 or suspect to have COVID-19 and are using a nebulizer at home should be aware that the virus may persist in droplets in the air for 1-2 hours. It is recommended that albuterol be nebulized in a location that minimizes exposure to members of your household who aren’t infected. [2], [3]

The Global Initiative for Asthma (GINA) recommends against the use of nebulizers (when possible) due to the increased risk of spreading COVID-19 to other patients and healthcare personnel. [4]

A letter from Canadian respirologists warns that COVID-19 demands greater infection control and precautions concerning the use of nebulizers. They state that nebulizers generate aerosol particles in the size of 1-5 micrometers, which can carry bacteria and viruses into the deep lung. Therefore the risk of bystander infection via droplet nuclei and aerosols may increase during nebulizer treatments because of the potential to generate a high volume of respiratory aerosols. In Alberta, Canada, nebulizer use is now restricted, only to be used in the following situations: patients with severe, life-threatening disease (respiratory arrest, end-stage COPD, cystic fibrosis); patients uncooperative or unable to follow directions for a metered-dose inhaler (MDI) with spacer; or patients with a history of poor response to MDI with spacer. The authors note that, though there is a lack of evidence showing superiority or inferiority of nebulizers to MDI with valved holding-chamber, nebulizers are still widely used. They encourage all caregivers to align with these restrictions and avoid nebulizers unless absolutely necessary in order to keep patients and staff safe. [5]

An article discusses the aerosol transmission of different diseases, including coronavirus (SARS), and ways to prevent infection. Short-range transmission implies that air that flows between individuals may interact to infect one another. The use of oxygen masks and nebulizers may generate a short-range infectious aerosol (<1 m) that could potentially infect healthcare workers and other patients. Also note that some droplets generated by such masks can evaporate to become droplet nuclei, which can transmit infection over longer distances, achieving more of a long-range or airborne quality. It is possible to reduce the risk of aerosol transmission by altering ventilation parameters in healthcare environments. Reducing infection risk also requires the use of PPE, contact-transmission precautions (hand-washing, avoid touching mucous membranes), keeping isolation room doors closed, manipulation of airflow in various ways (negative pressure rooms, sliding doors) can help reduce airborne concentrations of infectious droplets, and proper quarantine and isolation procedures. [6]

References:

[1] Centers for Disease Control and Prevention. Interim Infection Prevention and Control Recommendation for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings. https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Finfection-control%2Fcontrol-recommendations.html#take_precautions Updated April 12, 2020. Accessed April 14, 2020.
[2] American College of Allergy, Asthma, and Immunology. Ask the Expert about COVID-19 - Q&A Continued. https://education.aaaai.org/expert_covid-19. Updated March 2020. Accessed April 14, 2020.
[3] American College of Allergy, Asthma, and Immunology. Important COVID-19 information for those with asthma and/or allergies. https://acaai.org/news/important-covid-19-information-those-asthma-andor-allergies. Updated April 9, 2020. Accessed April 14, 2020.
[4] Global Initiative for Asthma. COVID-19: GINA Answers To Frequently Asked Questions On Asthma Management. https://ginasthma.org/covid-19-gina-answers-to-frequently-asked-questions-on-asthma-management. Updated March 25, 2020. Accessed April 15, 2020.
[5] Amirav, I. Transmission of coronavirus by nebulizer: a serious, underappreciated risk. CMAJ 2020 March 30; 192:E346.
[6] Tang JW, Li Y, Eames I, Chan PK, Ridgway GL. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. J Hosp Infect. 2006;64(2):100-14.

Literature Review

A search of the published medical literature revealed 1 study investigating the researchable question:

What are the current recommendations for COVID-19 and nebulizer use? Should they be discontinued in the inpatient or LTC environment to reduce the risk of the spread of the virus even if there are no positive or PUI cases?

Please see Table 1 for your response.


 

Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient — Solano County, California, February 2020

Design

Retrospective chart review

N=37

Objective

To better characterize and compare exposures among healthcare personnel (HCP) who did and did not develop COVID-19

Study Groups

Developed COVID-19 (n=3)

Without COVID-19 (n=34)

Methods

On February 26, 2020, the first U.S. case of community-acquired coronavirus disease 2019 (COVID-19) was confirmed in a patient hospitalized in Solano County, California. There was 121 healthcare personnel exposed to this patient 11 days prior at a different hospital, before his diagnosis was confirmed. 

During this 4-day hospitalization, the patient was managed with standard precautions and underwent multiple aerosol-generating procedures (AGPs), including nebulizer treatments, bilevel positive airway pressure (BiPAP) ventilation, endotracheal intubation, and bronchoscopy. Later, the patient was transferred to a different hospital where the COVID-19 diagnosis was confirmed. 

This study conducted standardized interviews were conducted with 37 HCPs from the first hospital who were tested for SARS-CoV-2, including the three who had positive test results. Originally, 43 HCPs were tested, but only 37 were available for interview. 

Duration

February 26 to March 11, 2020

Outcome Measures

Risk factors for COVID-19 transmission

Baseline Characteristics

  All HCPs (N=43)    
Age, years (range) 39 (27-60)    
Female 36 (84%%)    
Registered nurse 22 (51%)    

Results

  COIVD-19 positive (n=3) COVID-19 negative (n=34) P-value

Aerosol generating procedures (AGPs)

Airway suctioning

Noninvasive ventilation

Manual ventilation

Nebulizer treatment

Intubation (either present or assisted when occurred)

 

0

2 (67%)

1 (33%)

2 (67%)

1 (33%)

 

7 (21%)

4 (12%)

2 (6%)

3 (9%)

2 (6%) 

 

1.00

0.06

0.23

0.04

0.23

Reported PPE use during AGPs

Gloves

Facemask

 

2/2 (100%)

0/2 (0%)

 

10/16 (63%)

3/16 (19%)

 

0.53

1.00

Study Author Conclusions

Exposures while performing physical examinations or during nebulizer treatments were more common among HCP with COVID-19.

InpharmD Researcher Critique

This was a retrospective study of only 3 positive HCPs. 



References:

Heinzerling A, Stuckey MJ, Scheuer T, et al. Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient — Solano County, California, February 2020. MMWR Morb Mortal Wkly Rep. 2020;[E-pub ahead of print].